Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
  1. 4 Open-market sale Chief Executive Officer sold 8,301 shares at an average $230.99 ($1,917,475)
  2. 4 Open-market sale EVP, Chief Financial Officer sold 1,605 shares at an average $231.00 ($370,747)
  3. 4 Open-market sale EVP, Chief Commercial Officer sold 1,605 shares at an average $231.00 ($370,747)
  4. 4 Open-market sale CSO & EVP, Head of Research sold 1,198 shares at an average $230.99 ($276,731)
  5. 4 Planned sale Director sold 21,700 shares at an average $148.60 ($3,224,546)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award EVP, Chief Commercial Officer acquired 4,751 shares (grant or award)
  19. 4 Grant or award CMO & EVP Dev & Med Affairs acquired 4,751 shares (grant or award)
  20. 4 Grant or award EVP, Chief Financial Officer acquired 7,741 shares (grant or award)

Page 7 of 47 · 936 filings